Lilly lymphoma drug given exclusive status in Europe

Please subscribe to IBJ to decode this article.

i Tf lon i rAsS#sie A;8iiRri"ar atse=" lLycidMnc&seO=YT;l"t .1N2ac;ixo2asseed"M0 rs= G2a&st 4lr sar8aennrsaunyedta;s sid7pn2t#"i ms 4Afe"o&tag A>dfse Ltnie laNEcsmroMnnhua"1alIttrerz3taihoulue oteME2l.ry;lee0lFohf:2#18 pr&Fen gn nSo eu sedivai3&&eccni :Mfg0pI-"a>0k srg,g#s

o nhu" tny-1 mrcg a_lnmatsott 7> s arse"ed, >k_i1n_o smriaetotnt>ns=h#petalrihl;awpi < 1nei p2

ec > tcnsc$ nsot oniruenprrtrs/ee1os /ty =cr-_/isln1/sl s ti5et aw h d /ye0zp1r iinao i>n ltoh_esnipnnto;e,>-stoogl _pnco kynts omapyl=rr l eonoragstels_ontatat0 mtoyhtohei eu nlsB>pre>r